 Children with asthma will be recruited and evaluated with a real life open label trial: they will be randomised into two groups at first visit T1: 1 group A: in these patients montelukast tablets 5 mg and as needed beta agonist will be administered; 2 group B: in these patients beta agonist therapy only. 